Second primary malignancy risk following radioactive iodine therapy for thyroid cancer: a population-based matched cohort study in Taiwan.

Lin SF, Lu YL, Wu CL, Chang SH, Wong RJ, Huang YT

Open source

DOI
10.1093/ejendo/lvag187
Published
2026 Oct 5
Container
European journal of endocrinology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ejendo/lvag187,
  title = {Second primary malignancy risk following radioactive iodine therapy for thyroid cancer: a population-based matched cohort study in Taiwan.},
  author = {Lin SF and Lu YL and Wu CL and Chang SH and Wong RJ and Huang YT},
  year = {2026},
  journal = {European journal of endocrinology},
  doi = {10.1093/ejendo/lvag187},
  url = {https://doi.org/10.1093/ejendo/lvag187}
}

RIS

TY  - JOUR
TI  - Second primary malignancy risk following radioactive iodine therapy for thyroid cancer: a population-based matched cohort study in Taiwan.
AU  - Lin SF
AU  - Lu YL
AU  - Wu CL
AU  - Chang SH
AU  - Wong RJ
AU  - Huang YT
PY  - 2026
JO  - European journal of endocrinology
DO  - 10.1093/ejendo/lvag187
UR  - https://doi.org/10.1093/ejendo/lvag187
ER  - 

APA

SF, L., YL, L., CL, W., SH, C., RJ, W., & YT, H. (2026). Second primary malignancy risk following radioactive iodine therapy for thyroid cancer: a population-based matched cohort study in Taiwan.. European journal of endocrinology. https://doi.org/10.1093/ejendo/lvag187

Source records